Avanos Medical (AVNS) Net Margin (2013 - 2026)

Avanos Medical has disclosed Net Margin across 14 years of filings, most recently posting 2.8% for Q1 2026.

• In Q1 2026, Net Margin fell 114.0% year-over-year to 2.8%; the TTM figure through Mar 2026 stood at 10.39% (up 4541.0% YoY), while the FY2025 annual figure was 10.4%, up 4661.0% from the prior year.
• Net Margin came in at 2.8% for Q1 2026 at Avanos Medical, up from 0.72% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 9.31% in Q4 2022 to a low of 221.21% in Q4 2024.
• Average Net Margin over 5 years is 15.59%, with a median of 1.05% recorded in 2024.
• Year-over-year, Net Margin slumped 22727 bps in 2024 and jumped 22050 bps in 2025.
• Over 5 years, Net Margin stood at 9.31% in 2022, then slumped by 35 bps to 6.06% in 2023, then slumped by 3751 bps to 221.21% in 2024, then jumped by 100 bps to 0.72% in 2025, then jumped by 490 bps to 2.8% in 2026.
• Per Business Quant data, the three most recent Net Margin figures were 2.8% in Q1 2026, 0.72% in Q4 2025, and 0.79% in Q3 2025.